Cancer
Early View
COMMENTARY

Androgen deprivation therapy and postprostatectomy radiation: What is the optimal duration?

David D. Yang MD, 

Corresponding Author

David D. Yang MD

Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Correspondence

David D. Yang, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, 75 Francis St, Boston, MA USA.

Email: [email protected]

Contribution: Conceptualization, Writing - original draft, ​Investigation, Writing - review & editing, Supervision

Search for more papers by this author
Jing Wu PhD, 

Jing Wu PhD

Department of Statistics, University of Rhode Island, Providence, Rhode Island, USA

Contribution: Formal analysis, ​Investigation, Methodology

Search for more papers by this author
Anthony V. D’Amico MD, PhD, 

Anthony V. D’Amico MD, PhD

Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Contribution: Conceptualization, ​Investigation, Writing - original draft, Supervision, Writing - review & editing

Search for more papers by this author
First published: 25 August 2024
https://doi.org/10.1002/cncr.35532

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

Data sharing is not applicable to this article as no new data were created or analyzed in this study.